Renovis' IPO

Renovis raised a round of funding on February 05, 2004. Investors include Public.

Renovis is a biopharmaceutical company that seeks to improve the lives of patients suffering from neurological disease with novel drugs that renew, restore, and repair the nervous system. The Company …

Articles about Renovis' IPO: